These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18692049

  • 1. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
    Harrison SM, Whitehouse A.
    FEBS Lett; 2008 Sep 03; 582(20):3080-4. PubMed ID: 18692049
    [Abstract] [Full Text] [Related]

  • 2. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD, Khadim F, Spadavecchia S, Palmeri D, Lukac DM.
    J Virol; 2007 Aug 03; 81(16):8451-67. PubMed ID: 17537858
    [Abstract] [Full Text] [Related]

  • 3. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
    Lukac DM, Garibyan L, Kirshner JR, Palmeri D, Ganem D.
    J Virol; 2001 Aug 03; 75(15):6786-99. PubMed ID: 11435557
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta.
    Bowser BS, Morris S, Song MJ, Sun R, Damania B.
    Virology; 2006 May 10; 348(2):309-27. PubMed ID: 16546233
    [Abstract] [Full Text] [Related]

  • 5. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS, Izumiya Y, Speck SH.
    J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795414
    [Abstract] [Full Text] [Related]

  • 6. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
    Staudt MR, Dittmer DP.
    Virology; 2006 Jun 20; 350(1):192-205. PubMed ID: 16616289
    [Abstract] [Full Text] [Related]

  • 7. The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression.
    West JT, Wood C.
    Oncogene; 2003 Aug 11; 22(33):5150-63. PubMed ID: 12910252
    [Abstract] [Full Text] [Related]

  • 8. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
    Nishimura K, Ueda K, Sakakibara S, Ishikawa K, Chen J, Okuno T, Yamanishi K.
    J Hum Virol; 2001 Aug 11; 4(6):296-305. PubMed ID: 12082396
    [Abstract] [Full Text] [Related]

  • 9. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.
    Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D.
    Genes Dev; 2002 Aug 01; 16(15):1977-89. PubMed ID: 12154127
    [Abstract] [Full Text] [Related]

  • 10. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y, Ganem D.
    Proc Natl Acad Sci U S A; 2003 Jul 08; 100(14):8490-5. PubMed ID: 12832621
    [Abstract] [Full Text] [Related]

  • 11. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE, Wu FY, Yu Y, Hayward GS.
    J Virol; 2003 Sep 08; 77(17):9590-612. PubMed ID: 12915572
    [Abstract] [Full Text] [Related]

  • 12. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
    Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM.
    J Virol; 2006 Oct 08; 80(19):9697-709. PubMed ID: 16973574
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of the open reading frame 35 encoded by Kaposi's sarcoma-associated herpesvirus.
    Masa SR, Lando R, Sarid R.
    Virology; 2008 Feb 05; 371(1):14-31. PubMed ID: 17963810
    [Abstract] [Full Text] [Related]

  • 14. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    AuCoin DP, Colletti KS, Cei SA, Papousková I, Tarrant M, Pari GS.
    Virology; 2004 Jan 20; 318(2):542-55. PubMed ID: 14972523
    [Abstract] [Full Text] [Related]

  • 15. Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus.
    Wang SS, Chang PJ, Chen LW, Chen LY, Hung CH, Liou JY, Yen JB.
    Virus Res; 2012 May 20; 165(2):157-69. PubMed ID: 22366521
    [Abstract] [Full Text] [Related]

  • 16. Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.
    Sakakibara S, Ueda K, Chen J, Okuno T, Yamanishi K.
    J Virol; 2001 Aug 20; 75(15):6894-900. PubMed ID: 11435569
    [Abstract] [Full Text] [Related]

  • 17. Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro.
    Ziegelbauer J, Grundhoff A, Ganem D.
    J Virol; 2006 Mar 20; 80(6):2958-67. PubMed ID: 16501105
    [Abstract] [Full Text] [Related]

  • 18. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K, Murakami M, Choudhuri T, Kuppers DA, Robertson ES.
    Virology; 2006 Aug 01; 351(2):393-403. PubMed ID: 16701788
    [Abstract] [Full Text] [Related]

  • 19. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11.
    Chen L, Park MS.
    Virus Res; 2009 Jun 01; 142(1-2):160-8. PubMed ID: 19428749
    [Abstract] [Full Text] [Related]

  • 20. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.
    Liang Y, Ganem D.
    J Virol; 2004 Jul 01; 78(13):6818-26. PubMed ID: 15194757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.